391
Views
0
CrossRef citations to date
0
Altmetric
CASE SERIES

Transient Increase in Patient Numbers with “Acute Macular Neuroretinopathy” Post SARS-CoV-2 Infection—Case Series During the First Surge of Infection in December 2022

, , , &
Pages 2763-2771 | Received 24 Apr 2023, Accepted 15 Jun 2023, Published online: 03 Jul 2023

References

  • Hu K, Patel J, Swiston C, Patel BC. Ophthalmic manifestations of coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. PMID: 32310553.
  • Orphanet. Acute macular neuroretinopathy. Available from: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=488239. Accessed June 23, 2023.
  • Bhavsar KV, Lin S, Rahimy E, et al. Acute macular neuroretinopathy: a comprehensive review of the literature. Surv Ophthalmol. 2016;61(5):538–565. PMID: 26973287. doi:10.1016/j.survophthal.2016.03.003
  • Ahmed W, Suri A, Ahmed A. COVID-19 and acute macular neuroretinopathy - an underlying association? Ann Med Surg. 2022;78:103847. PMID: 35734676; PMCID: PMC9207085. doi:10.1016/j.amsu.2022.103847
  • Jalink MB, Bronkhorst IHG. A sudden rise of patients with acute macular neuroretinopathy during the COVID-19 pandemic. Case Rep Ophthalmol. 2022;13(1):96–103. PMID: 35350236; PMCID: PMC8921888. doi:10.1159/000522080
  • Dinh RH, Tsui E, Wieder MS, et al. Acute macular neuroretinopathy and coronavirus disease 2019. Ophthalmol Retina. 2023;7(2):198–200. PMID: 36216223; PMCID: PMC9546455. doi:10.1016/j.oret.2022.09.005
  • Azar G, Bonnin S, Vasseur V, et al. Did the COVID-19 pandemic increase the incidence of acute macular neuroretinopathy? J Clin Med. 2021;10(21):5038. PMID: 34768555; PMCID: PMC8585041. doi:10.3390/jcm10215038
  • Bos PJ, Deutman AF. Acute macular neuroretinopathy. Am J Ophthalmol. 1975;80(4):573–584. PMID: 1180301. doi:10.1016/0002-9394(75)90387-6
  • Casalino G, Arrigo A, Romano F, Munk MR, Bandello F, Parodi MB. Acute macular neuroretinopathy: pathogenetic insights from optical coherence tomography angiography. Br J Ophthalmol. 2019;103(3):410–414. PMID: 29844084. doi:10.1136/bjophthalmol-2018-312197
  • Zhou L, Xu Z, Guerra J, et al. Expression of the SARS-CoV-2 receptor ACE2 in human retina and diabetes-implications for retinopathy. Invest Ophthalmol Vis Sci. 2021;62(7):6. PMID: 34086044; PMCID: PMC8185397. doi:10.1167/iovs.62.7.6
  • Reinhold A, Tzankov A, Matter MS, Mihic-Probst D, Scholl HPN, Meyer P. Ocular pathology and occasionally detectable intraocular severe acute respiratory syndrome Coronavirus-2 RNA in five fatal Coronavirus disease-19 cases. Ophthalmic Res. 2021;64(5):785–792. PMID: 33472206. doi:10.1159/000514573
  • Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017–1032. PMID: 32651579. doi:10.1038/s41591-020-0968-3
  • Amin P, Cox TA. Acute macular neuroretinopathy. Arch Ophthalmol. 1998;116(1):112–113. PMID: 9445223. doi:10.1001/archopht.116.1.112
  • Neuhann IM, Inhoffen W, Koerner S, Bartz-Schmidt KU, Gelisken F. Visualization and follow-up of acute macular neuroretinopathy with the Spectralis HRA+OCT device. Graefes Arch Clin Exp Ophthalmol. 2010;248(7):1041–1044. PMID: 20198487. doi:10.1007/s00417-010-1324-y
  • Aidar MN, Gomes TM, de Almeida MZH, de Andrade EP, Serracarbassa PD. Low visual acuity due to acute macular neuroretinopathy associated with COVID-19: a case report. Am J Case Rep. 2021;22:e931169. PMID: 33930011; PMCID: PMC8097744. doi:10.12659/AJCR.931169
  • Valenzuela DA, Groth S, Taubenslag KJ, Gangaputra S. Acute macular neuroretinopathy following Pfizer-BioNTech COVID-19 vaccination. Am J Ophthalmol Case Rep. 2021;24:101200. PMID: 34485760; PMCID: PMC8409052. doi:10.1016/j.ajoc.2021.101200
  • Miller MH, Spalton DJ, Fitzke FW, Bird AC. Acute macular neuroretinopathy. Ophthalmology. 1989;96(2):265–269. PMID: 2704546. doi:10.1016/s0161-6420(89)32906-x
  • Drüke D, Pleyer U, Hoerauf H, Feltgen N, Bemme S. Acute macular neuroretinopathy (AMN) following COVID-19 vaccination. Am J Ophthalmol Case Rep. 2021;24:101207. PMID: 34580648; PMCID: PMC8457905. doi:10.1016/j.ajoc.2021.101207
  • Fekri S, Khorshidifar M, Dehghani MS, Nouri H, Abtahi SH. Acute macular neuroretinopathy and COVID-19 vaccination: case report and literature review. J Fr Ophtalmol. 2023;46(1):72–82. PMID: 36496293; PMCID: PMC9684098. doi:10.1016/j.jfo.2022.09.008
  • Rennie AT, DeWeerd AJ, Martinez MG, Kay CN. Acute macular neuroretinopathy following COVID-19 mRNA Vaccination. Cureus. 2022;14(7):e27502. PMID: 36060339; PMCID: PMC9426360. doi:10.7759/cureus.27502
  • Mambretti M, Huemer J, Torregrossa G, Ullrich M, Findl O, Casalino G. Acute macular neuroretinopathy following Coronavirus disease 2019 vaccination. Ocul Immunol Inflamm. 2021;29(4):730–733. PMID: 34187278. doi:10.1080/09273948.2021.1946567
  • Franchi A, Rauchegger T, Palme C, et al. Two cases of acute macular neuroretinopathy associated with the adenovirus-based COVID-19 vaccine vaxzevria (AstraZeneca). Ocul Immunol Inflamm. 2022;30(5):1234–1239. PMID: 35050829. doi:10.1080/09273948.2022.2027463
  • Book BAJ, Schmidt B, Foerster AMH. Bilateral acute macular neuroretinopathy after vaccination against SARS-CoV-2. JAMA Ophthalmol. 2021;139(7):e212471. PMID: 34287612. doi:10.1001/jamaophthalmol.2021.2471
  • Bøhler AD, Strøm ME, Sandvig KU, Moe MC, Jørstad ØK. Acute macular neuroretinopathy following COVID-19 vaccination. Eye. 2022;36(3):644–645. PMID: 34158652; PMCID: PMC8217204. doi:10.1038/s41433-021-01610-1.